SARS CoV-2 Spike Glycoprotein UK variant Antibody FITC

General Information

Product

SARS CoV-2 Spike Glycoprotein UK variant Antibody FITC

Description

FITC-Conjugated SARS CoV-2 Spike Glycoprotein UK variant Antibody

Verified Applications

ELISA, IP, WB

Host

Rabbit

Species Cross Reactivity

Virus

Immunogen

Synthetic peptide corresponding to amino acids within region 650-800 SARS CoV-2 Spike Glycoprotein UK variant.

Physical Properties

Quantity

100 µg

Concentration

0.5-1.5 µg/µl in antibody stabilization buffer

Immunoglobulin

IgG

Conjugate

FITC

Purification Method

Immobilized antigen affinity chromatography

Clonality

Polyclonal

Storage

-20°C for long term storage

Application Protocol

ELISA

1:10,000

Immunocytochemistry

1:50-1:100

Immunofluorescence

1:50-1:100

Immunohistochemistry

1:50-1:100

Immunoprecipitation

1:200

Western Blot

1:500

Protein

Uniprot #

P0DTC2

Molecular Function

host cell surface receptor binding

identical protein binding

Subcellular Location

Virion membrane, Single-pass type I membrane protein

Host endoplasmic reticulum-Golgi intermediate compartment membrane; Single-pass type I membrane protein�

Host cell membrane; Single-pass type I membrane protein

Structure

Coiled coil, Signal, Transmembrane, Transmembrane helix

Alternative Nomenclature

Coronavirus Spike Antibody

COVID Spike antibody

COVID19 Spike antibody

COVID19 Spike UK Variant antibody

COVID19 Spike Glycoprotein antibody

Spike antibody

Spike UK variant antibody

Sars COV2 Spike Glycoprotein antibody

SARS-CoV-2 Spike Glycoprotein antibody

SARS Cov-2 Spike Glycoprotein UK variant antibody

SARS Cov-2 Spike UK variant antibody